Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (789)
Guidance programme
(
2 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 651 to 700 of 789
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
TA305
26 February 2014
26 February 2014
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma
TA306
26 February 2014
26 February 2014
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
TA300
27 November 2013
27 November 2013
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)
TA302
27 November 2013
27 November 2013
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
TA106
23 August 2006
1 November 2013
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
TA75
28 January 2004
1 November 2013
Pazopanib for the first-line treatment of advanced renal cell carcinoma
TA215
23 February 2011
1 August 2013
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder
TA292
24 July 2013
24 July 2013
Aflibercept solution for injection for treating wet age‑related macular degeneration
TA294
24 July 2013
24 July 2013
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
TA287
26 June 2013
26 June 2013
Mirabegron for treating symptoms of overactive bladder
TA290
26 June 2013
26 June 2013
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer
TA284
22 May 2013
22 May 2013
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer
TA285
22 May 2013
22 May 2013
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)
TA286
22 May 2013
22 May 2013
Omalizumab for treating severe persistent allergic asthma
TA278
24 April 2013
24 April 2013
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures
TA279
24 April 2013
24 April 2013
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis
TA276
27 March 2013
27 March 2013
Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal)
TA277
27 March 2013
27 March 2013
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract
TA272
23 January 2013
23 January 2013
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)
TA273
23 January 2013
23 January 2013
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma
TA268
12 December 2012
12 December 2012
Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)
TA270
12 December 2012
12 December 2012
Dronedarone for the treatment of non-permanent atrial fibrillation
TA197
25 August 2010
1 December 2012
Mannitol dry powder for inhalation for treating cystic fibrosis
TA266
28 November 2012
28 November 2012
Ivabradine for treating chronic heart failure
TA267
28 November 2012
28 November 2012
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours
TA265
24 October 2012
24 October 2012
Alteplase for treating acute ischaemic stroke
TA264
26 September 2012
26 September 2012
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
TA263
22 August 2012
22 August 2012
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
TA261
25 July 2012
25 July 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2
TA257
27 June 2012
27 June 2012
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
TA258
27 June 2012
27 June 2012
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine
TA260
27 June 2012
27 June 2012
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis
TA254
25 April 2012
25 April 2012
Pharmalgen for the treatment of bee and wasp venom allergy
TA246
22 February 2012
22 February 2012
Tocilizumab for the treatment of rheumatoid arthritis
TA247
22 February 2012
22 February 2012
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy
TA242
25 January 2012
25 January 2012
Rituximab for the first-line treatment of stage III-IV follicular lymphoma
TA243
25 January 2012
25 January 2012
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults
TA245
25 January 2012
25 January 2012
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
TA118
24 January 2007
1 January 2012
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
TA238
14 December 2011
14 December 2011
Fulvestrant for the treatment of locally advanced or metastatic breast cancer
TA239
14 December 2011
14 December 2011
Ticagrelor for the treatment of acute coronary syndromes
TA236
26 October 2011
26 October 2011
Mifamurtide for the treatment of osteosarcoma
TA235
26 October 2011
26 October 2011
Bortezomib and thalidomide for the first‑line treatment of multiple myeloma
TA228
27 July 2011
27 July 2011
Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion
TA229
27 July 2011
27 July 2011
Agomelatine for the treatment of major depressive episodes (terminated appraisal)
TA231
27 July 2011
27 July 2011
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction
TA73
26 November 2003
1 July 2011
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer
TA227
29 June 2011
29 June 2011
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs
TA225
22 June 2011
22 June 2011
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
TA226
22 June 2011
22 June 2011
Previous page
1
…
12
13
Current page
14
15
16
Page
14
of
16
Next page
Results per page
10
25
50
All
Back to top